Acute monocytic leukemia presenting as acute respiratory failure. 2003

Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
Medical Intensive Care Unit, Hematology Department, Saint-Louis Teaching Hospital, Paris 7 University, France. elie.azoulay@sls.ap-hop-paris.fr

Acute respiratory failure revealing acute monocytic leukemia is rare. We report 20 patients admitted to the intensive care unit (ICU) with three remarkable features: (1) rapidly progressive respiratory distress revealing acute leukemia, (2) monocytic leukemia, and (3) respiratory status deterioration after chemotherapy initiation. The median age was 50 years (17-72 years), and respiratory symptoms started 2 days (0-15 days) before ICU admission. The median leukocyte count was 98,250/mm3 (800-529,000), with circulating monocytic cells in all of the patients but one. Bone marrow examination was diagnostic of monocytic leukemia in all patients. At presentation, respiratory rate was 33 (18-50) per minute, and PaO2 on room air was 44.5 mm Hg (30-60). Chest radiographs revealed unilateral alveolar infiltrates (n = 1), bilateral alveolar infiltrates with (n = 3) or without (n = 11) pleural effusion, or diffuse interstitial infiltrates (n = 5). Alveolar hemorrhage was the main bronchoalveolar lavage finding, with monocytic cells retrieved from four patients. Respiratory function deteriorated after cancer chemotherapy initiation in all patients. Of the 15 patients who required mechanical ventilation, 10 died. Leukemic pulmonary infiltration as the first manifestation of acute monocytic leukemia should be recognized, and intensive management should be provided in anticipation of the respiratory function deterioration seen consistently after chemotherapy initiation.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
January 1999, Dermatology (Basel, Switzerland),
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
November 2020, International journal of hematology,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
June 1971, Archives of pathology,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
February 1974, The Journal of pediatrics,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
November 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
March 2005, Southern medical journal,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
February 2007, Nature clinical practice. Nephrology,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
November 1978, Intensive care medicine,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
February 1988, Surgical neurology,
Elie Azoulay, and Fabienne Fieux, and Delphine Moreau, and Guillaume Thiery, and Philippe Rousselot, and Antoine Parrot, and Jean-Roger Le Gall, and Hervé Dombret, and Benoît Schlemmer
September 1992, Anales de medicina interna (Madrid, Spain : 1984),
Copied contents to your clipboard!